New York State Common Retirement Fund Avadel Pharmaceuticals PLC Transaction History

New York State Common Retirement Fund

  • $73.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
BUY
$12.55 - $17.22 $5.01 Million - $6.88 Million
399,551 New
399,551 $6.75 Million
Q2 2019

Aug 09, 2019
SELL
$1.09 - $3.19 $6,776 - $19,832
-6,217 Closed
0 $0
Q1 2019

May 08, 2019
SELL
$1.44 - $3.29 $13,446 - $30,722
-9,338 Reduced 60.03%
6,217 $9,000
Q2 2018

Aug 10, 2018
BUY
$5.89 - $7.78 $91,618 - $121,017
15,555 New
15,555 $95,000

Others Institutions Holding AVDL

# of Institutions
8
Shares Held
1.07M
Call Options Held
0
Put Options Held
0
View Full List

About AVADEL PHARMACEUTICALS PLC

AVDL Quotes by TradingView
  • Ticker AVDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 60,581,300
  • Market Cap $661M
  • Description
  • Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...
More about AVDL
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email